[Infections of a fungal etiology in the cancer clinic]

Area of Science:

• Mycology
• Oncology
• Infectious Diseases

Background:

• Candida species are common contaminants in pathological samples from cancer patients, accounting for up to 28% of microflora.
• These fungi can be isolated alone or with bacteria, highlighting their significant role in infectious processes.
• The effectiveness of antifungal therapies confirms the pathogenic importance of Candida in this population.

Purpose of the Study:

• To emphasize the necessity of accurate taxonomic identification of fungal cultures.
• To highlight the prevalence and significance of Candida infections in cancer patients.

Main Methods:

• Isolation and identification of fungal cultures from pathological materials.
• Analysis of contamination rates and co-occurrence with bacterial species.

Main Results:

• Candida species, predominantly Candida albicans, are found in a significant proportion of pathological samples from cancer patients.
• Fungal contamination can occur as a monoculture or in association with bacteria.

Conclusions:

• The high prevalence of Candida infections in cancer patients underscores the need for precise identification methods.
• Effective antimycotic therapy and prophylactic measures are essential for managing these infections.